SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-044762
Filing Date
2021-08-17
Accepted
2021-08-16 20:04:14
Documents
92
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 JUNE 30 2021 10-Q ffntf-10q_20210630.htm   iXBRL 10-Q 2775145
2 EX-31.1 ffntf-ex311_87.htm EX-31.1 28627
3 EX-31.2 ffntf-ex312_88.htm EX-31.2 26714
4 EX-32.1 ffntf-ex321_89.htm EX-32.1 13059
  Complete submission text file 0001564590-21-044762.txt   12350013

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ffntf-20210630.xsd EX-101.SCH 92552
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ffntf-20210630_cal.xml EX-101.CAL 84558
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ffntf-20210630_def.xml EX-101.DEF 249078
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ffntf-20210630_lab.xml EX-101.LAB 604578
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ffntf-20210630_pre.xml EX-101.PRE 459352
10 EXTRACTED XBRL INSTANCE DOCUMENT ffntf-10q_20210630_htm.xml XML 2874281
Mailing Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3
Business Address 2900-550 BURRARD STREET VANCOUVER A1 V6C 0A3 (602) 682-7037
4Front Ventures Corp. (Filer) CIK: 0001783875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56075 | Film No.: 211180593
SIC: 2833 Medicinal Chemicals & Botanical Products